Zdrowie i gospodarka · 07/08/2017
FDA Requests Public Comment on Proposed Collection of Information for Licensed Biologics
The Food and Drug Administration is seeking public input on a proposed extension of information collection related to cooperative manufacturing arrangements for licensed biologics, as required by the Paperwork Reduction Act of 1995.